Esperion Therapeutics
ESPR
$1.99
Share price
-6.57%
Change (1 day)
65.83%
Change (1 year)
Categories
Operating Margin for Esperion Therapeutics (ESPR)
Operating Margin as of April 2024 (TTM): -343.04%
According to Esperion Therapeutics's latest financial reports and stock price the company's current Operating Margin is -343.04%. At the end of 2021 the company had an Operating Margin of -343.04%.
Operating Margin history for Esperion Therapeutics from 2019 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -343.04% | 443.77% |
| 2020 | -63.09% | -3.67% |
| 2019 | -65.49% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 34.61% | -110.09% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | 37.68% | -110.98% | 🇺🇸 USA |
 Ultragenyx RARE | -162.16% | -52.73% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | -87,620.60% | 25,442.39% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | -55.07% | -83.95% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 4.83% | -101.41% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.